Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D2018
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 996 $6,123,438 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $6,123,438 Current and potential, with all options
- Last date to order 10% complete
- IDV ceiling 1% used
- $999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D2018 is a $999,999,999 single-award contract issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract's purpose is to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This IDC serves as a primary vehicle for DLA to efficiently procure essential medical commodities across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The contract has a 30-month base period with three 30-month option periods, running through December 2036. This IDC is part of the DLA's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which aims to establish multiple regional primary supplier contracts to enhance the Department of Defense's pharmaceutical supply chain resiliency.
The original federal contract opportunity, posted in February 2024, sought to solicit bids for the PPV-G GEN V program through an unrestricted, fully competitive acquisition. The DLA Troop Support Medical intends to make multiple regional primary supplier awards, with at least three different contractors selected, as well as a separate backup supplier contract. The contract will be a firm-fixed-price, requirements-type contract, with awards based on the lowest overall price considering distribution fees for brand/generic and specialty drugs. The total estimated value for all regions and options is $30.3 billion.
Task orders
Show 40 more
Latest 50 of 996 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D2018?
SPE2DR25D2018 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 1, 2025.
How much is contract SPE2DR25D2018 worth?
Orders under SPE2DR25D2018 have obligated $6,123,438. SPE2DR25D2018's own ceiling is $999,999,999.
How many orders have been placed under contract SPE2DR25D2018?
996 orders have been placed under SPE2DR25D2018, the latest on July 24, 2026.
Who can order from contract SPE2DR25D2018?
SPE2DR25D2018 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D2018 competed?
The extent of competition for SPE2DR25D2018 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV